Stand no: 20E23
Excelsyn Molecular Development excels at providing a broad range of cost-effective process r&d services spanning lab, kilo, pilot and plant scales for both advanced intermediates and APIs under either GMP or non-GMP conditions, as appropriate.
As part of the Excelsyn Group, formed in 2004 by Ian Shott, we focus on the drug development challenges faced by the pharmaceutical industry.
During the last three years the rapid expansion and growth of our customer base has been based on the ability to deliver innovative solutions in a timely manner by the provision of a flexible and highly interactive approach.